Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
71.46
-0.26 (-0.36%)
At close: Apr 2, 2026, 4:00 PM EDT
72.88
+1.42 (1.99%)
After-hours: Apr 2, 2026, 7:48 PM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$556,655
Market Cap
689.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Maravai LifeSciences Holdings | 435 |
| MeiraGTx Holdings | 403 |
| Kura Oncology | 260 |
| Arvinas | 246 |
| Vor Biopharma | 154 |
| Solid Biosciences | 121 |
| BridgeBio Oncology Therapeutics | 92 |
DRUG News
- 4 weeks ago - Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
- 5 weeks ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 6 weeks ago - BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News - GuruFocus
- 3 months ago - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - GlobeNewsWire
- 3 months ago - Bright Minds Biosciences (DRUG) Prices $175M Public Offering - GuruFocus
- 3 months ago - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - GlobeNewsWire
- 3 months ago - Bright Minds Biosciences: Positive BREAKTHROUGH Study Data Warrants 'Strong Buy' Rating - Seeking Alpha
- 3 months ago - Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga